No conviction changes recorded
Fair Value Distribution — percentile bands
100.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
-2.3%/yr
±10.2% · revenue growth to justify current price
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
Eagle will generate this view by the next trading session (~6h).
Eagle will generate this view by the next trading session (~6h).
Medical cost inflation crisis (MCR 91.7%) offsets strong revenue growth. Strategic pullback from Medicare MAPD and low-margin Marketplace to focus on Medicaid. Earnings remain pressured in 2026-2027 b...